savolitinib,sunitinib,cabozantinib,crizotinib,nivolumab,ipilimumab,Avelumab,Axitinib,pembrolizumab,Lenvatinib
astrazeneca,bms,pfizer,exelixis,hutchmed,merck,eisai
['gu ', 'in-person', 'pdigree', 'papmet', 'renal,(-adrenal)', 'probe']
happening now! nctn trials in renal cell carcinoma investigator meeting! highlighting #pdigree #probe #radical #samurai #papmet2 trials! #nci 2023 asco gu symposium . . . . . 
Utilizing the best science to develop promising new cancer therapies and prevention strategies for cancer.